Stephanie Okey
CIK 1742616 · last filed 2026-06-22
Stephanie Okey is a corporate insider who has filed 44 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for CRNX, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$3.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.64M
4
44
-$3.14M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRNX | Director | 12,325 | $83.85 | $1.03M | -$1.18M | 11 | 2026-06-22 |
| PTCT | Director | 8,000 | $75.86 | $606.9K | -$1.96M | 16 | 2026-03-12 |
| Catalent, Inc. (CTLT) Delisted | Director | 0 | $63.48 | $0 | $0 | 4 | 2024-12-18 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Director | — | $44.15 | — | $0 | 7 | 2023-03-02 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | CRNX | Grant (A) | +5,925 | $0 | EDGAR |
| 2026-06-18 | CRNX | Sell (S) | −6,900 | -$246.1K | EDGAR |
| 2026-06-17 | CRNX | Notice (144) | −6,900 | -$241.5K | EDGAR |
| 2026-03-12 | PTCT | Mixed | — | -$551.6K | EDGAR |
| 2026-03-10 | PTCT | Notice (144) | −15,167 | -$1.06M | EDGAR |
| 2026-03-09 | PTCT | Sell (S) | −6,333 | -$401.4K | EDGAR |
| 2026-03-05 | PTCT | Notice (144) | −6,333 | -$401.4K | EDGAR |
| 2026-03-04 | CRNX | Sell (S) | −3,000 | -$119.0K | EDGAR |
| 2026-03-03 | CRNX | Notice (144) | −3,000 | -$122.0K | EDGAR |
| 2026-01-06 | PTCT | Grant (A) | +4,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.